Talon Leukemia Treatment Wins Backing of FDA Advisory Panel

Talon Therapeutics Inc., a biotechnology company with no marketed products, won the backing of a U.S. advisory panel for accelerated approval of its blood-cancer treatment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.